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The structural formulae are shown in Scheme 1. It is also effective in Zollinger-Ellison syndrome and in preventing ulcer rebleeding. Thus pantoprazole is a valuable alternate to other PPIs in the treatment of acid-related disorders. The drug is officially listed in Martindale The Extra Pharmacopoeia. 2 The assay of drug in bulk and dosage forms is not announced in any pharmacopoeia and therefore requires much more investigation in order to assure the exact quantity of drug in pharmaceutical formulations. A literature survey reveals that high performance liquid chromatography, [3] [4] [5] capillary zone electrophoresis, 6 and voltammetry 7 have been employed for its quantification. The above-mentioned techniques, of course, are sensitive enough but are expensive. Spectrophotometry is the technique of choice even today due to its inherent simplicity. It is frequently used in the laboratories of the developing countries to overcome a variety of analytical problems. In the literature only a few spectrophotometric methods have been reported. Two derivative spectrophometric procedures 8, 9 have been described for the determination of pantoprazole in drug formulations. The drug content in pharmaceutical preparations has been determined spectrophotometrically 10 in the visible region based on the reaction of drug with Fe(III) to form an orange-colored chelate, which absorbed maximally at 455 nm. The drug forms a ternary complex with eosin and copper, which is a basis for its analysis at 549 nm. 11 The charge transfer complexation reaction between the drug and 2,3-dichloro-5,6-dicyano-1,4-benzoquinone or iodine has been used to quantify the drug spectrophotometrically. 11 A kinetic spectrophotometric method based on the reaction of pantoprazole with 1-fluoro-2,4-dinitrobenzene in dimethyl sulfoxide medium 12 has been reported; this showed a linear response over the concentration range of 10.0 -20.0 μg ml -1 .
In this paper, a kinetic spectrophotometric method for the determination of pantoprazole in drug formulations is described. The method is based on the oxidation of pantoprazole with Fe(III) in sulfuric acid medium; Fe(III) subsequently reduced to Fe(II), which reacts with potassium ferricyanide to form a Prussian blue product, absorbing maximally at 725 nm. The initial-rate method is applied for the determination of pantoprazole. The method is optimized and validated as per the guidelines of the International Conference on Harmonisation. 13 
Materials and reagents
All chemicals and reagents were of analytical or pharmaceutical grade. Pantoprazole was kindly supplied by Concept Pharma Ltd. (Mumbai, India) and was used as the reference standard. A standard solution of pantoprazole (0.1%) was prepared by dissolving 50 mg in 50 ml distilled water. Pharmaceutical formulations of pantoprazole such as Pantec 20 (Concept, Mumbai, India) and Pantodac 20 (Zydus Cadila, Ahmedabad, India) were purchased from local markets.
Ammonium ferric sulfate (3.0 × 10 -3 M; Fluka Chemie AG, Switzerland) solution was prepared by dissolving 144.66 mg of ammonium ferric sulfate in 0.003 M sulfuric acid. Potassium ferricyanide (2.5 × 10 -3 M; Fluka Chemie AG, Switzerland) solution was prepared in distilled water.
Recommended procedure
Aliquots of 0.05 -0.9 ml standard solutions of pantoprazole were pipetted into a series of 10.0 ml standard volumetric flasks. To each flask, 1.7 ml of 3.0 × 10 -3 M ammonium ferric sulfate was added, followed by 1.5 ml of 2.5 × 10 -3 M potassium ferricyanide. Then the mixture was diluted to volume with distilled water at 35 ± 1˚C. The contents of each flask were mixed well and then immediately transferred to the spectrophotometric cell. The increase in absorbance was recorded at 725 nm as a function of time for 8.0 min. The initial rate of the reaction (ν) at different concentrations was obtained from the slope of the initial tangent to the absorbance-time curve. The calibration graph was constructed by plotting the initial rate of reaction, ν versus concentration of pantoprazole (C, μg ml -1 ). The amount of the drug was evaluated either from the calibration graph or from the regression equation.
Procedure for the determination of pantoprazole in pharmaceutical formulations
The quality control sample solution containing pantoprazole at a concentration of 1.0 mg ml -1 was prepared. The contents of 5 tablets of 20 mg strength were obtained by gentle peeling of the hard coated shells. The contents of the tablets were put in distilled water and left for 10.0 min for complete dispersion of the drug. Then the solution was filtered through a piece of Whatmann No. 42 filter paper (Whatmann International Limited, Kent, UK) in a 100 ml standard volumetric flask. The residue was washed well with distilled water for complete recovery of the drug and then the mixture was diluted up to the mark with distilled water. The assay was completed following the proposed procedure for the determination of pantoprazole.
Procedure for the determination of pantoprazole in synthetic mixtures
Synthetic mixtures of pantoprazole were prepared by taking various excipients commonly used in tablet dosage forms with 800 μg of pantoprazole in 10 ml standard volumetric flask and tested to study the interferences of excipients such as sodium stearyl fumarate, magnesium stearate, corn starch, lactose and talc.
Procedure for reference method 11 Aliquots of 0.1 -0.6 ml of 0.1% pantoprazole were pipetted into a series of 10 ml standard volumetric flasks. To each flask, 6.0 ml of 0.4% 2,3-dichloro-5,6-dicyano-1,4-benzoquinone was added and the mixture was diluted to volume with acetonitrile. The absorbance was measured against the reagent blank at 457 nm. The amount of the drug in a given sample was computed from the calibration graph.
Validation
The proposed kinetic method has been validated for specificity, linearity, limit of detection, precision, accuracy and recovery. Specificity. The reference standard and quality control samples of pantoprazole were subjected to stress conditions of light, heat, acid, base and oxidants. Each stressed sample was measured to determine the content of pantoprazole and the results were compared to those for an unstressed time zero reference solution.
The reference assay value for each unstressed product was evaluated and the contents of degradation in the stressed and control samples were estimated relative to this assay value. where S0 and b are the standard deviation and the slope of the calibration line. Precision and accuracy. Intra-day precision and accuracy of the proposed method were evaluated by replicate analysis (n = 5) of calibration standards at three concentration levels (20.0, 50.0, and 80.0 μg ml -1 ). Inter-day precision and accuracy were determined by assaying the calibration standards at the same concentration levels on five consecutive days. Precision and accuracy were based on the calculated relative standard deviation (RSD, %) and relative error (RE, %) of the found concentration compared to the theoretical one, respectively. Recovery studies.
The recovery of pantoprazole from commercial dosage forms was estimated by the standard addition method. For this purpose, a volume of 2.0 ml (or 5.0 ml) of sample solution was spiked with 2.0, 4.0, 6.0 and 7.0 ml (or 1.0, 2.0, 3.0 and 4.0) of reference standard solution (1.0 mg ml -1 ) in a 100 ml standard volumetric flask and the mixture was diluted up to the mark with distilled water. Each level was repeated 5 times. The nominal value was determined by the proposed procedure. Evaluation of bias. The point and interval hypothesis tests have been performed to compare the results of the proposed method with those of the reference method at 95% confidence level. The bias was evaluated by an interval hypothesis test based on the mean values of the proposed method (method 1) and the reference method (method 2). The test method is considered acceptable when its true mean is within ±2.0% of that of the reference method. This can be written as 0.98 < μ2/μ1 < 1.02 which can be generalized to θL < μ2/μ1 < θU where θL and θU are lower and upper acceptance limits, respectively, which were calculated from the following quadratic equation:
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Results and Discussion
Dialkyl/diaryl/alkyl-aryl sulfoxides undergo oxidation with a number of oxidants 16, 17 to form sulfone derivatives. Pantoprazole is a sulfoxide derivative that is oxidized in a similar manner by ammonium ferric sulfate in moderately acidic medium to form pantoprazole sulfone, 3 and itself reduces to Fe(II). The reduced Fe(II) immediately reacts with potassium ferricyanide, resulting in the formation of Prussian blue product, 18 which absorbs maximally at 725 nm. The absorbance of the colored solution increases with time and hence, a kinetically-based spectrophotometric method was elaborated to assay the pantoprazole in pharmaceutical formulations. The various experimental parameters affecting the formation of colored product were optimized and used throughout the experiment.
TLC study of pantoprazole and its oxidized product
To identify pantoprazole and pantoprazole sulfone, we used thin layer chromatography. The reference standard solutions of pantoprazole or of pantoprazole sulfone was applied on TLC plates coated with silica gel G (Merck, India) and developed in chloroform-methanol (10:0.7 v/v) solvent system. The plates were free from mobile phase, dried and spots were detected in iodine chamber. The Rf values were 0.54 and 0.66 for pantoprazole and pantoprazole sulfone, respectively. The Rf value (0.66) of the reaction product confirmed the presence of pantoprazole sulfone.
Optimization of variables
The optimum conditions for the proposed method responsible for the formation of the blue product were studied and maintained throughout the experiment. Effect of temperature. The effect of temperature on the initial rate of reaction was studied at 303, 308, 313 and 318 K. The absorbance-time curves showed that the reaction rate increases with increase in temperature. At temperature > 313 K, the linear dynamic range of determination decreases. The linear dynamic range, regression equation and correlation coefficient obtained at different temperatures are summarized in Table 1 . The best linearity was obtained at 308 K and hence this temperature was selected as an optimum temperature for the determination process. Table  2 . Therefore, a concentration of 5.10 × 10 -4 M ammonium ferric sulfate was recommended for the determination procedure. Effect of potassium ferricyanide concentration. The effect of potassium ferricyanide concentration on the initial rate of reaction (ν) was investigated in the range of 2.50 × 10 -5 -5.00 × 10 -4 M. The maximum value of the initial rate of reaction was obtained with 2.25 × 10 -4 M potassium ferricyanide, after which further increase in the concentration of potassium ferricyanide up to 5.00 × 10 -4 M resulted in no change in the initial rate of reaction (Table 2) . Thus, the concentration of 3.75 × 10 -4 M potassium ferricyanide was found to be most suitable concentration for the determination process.
Analytical data and method validation
The oxidation of pantoprazole takes place with Fe(III) in acidic medium, resulting in the formation of pantoprazole sulfone; subsequently, reduced Fe(II) reacts with potassium ferricyanide to form the blue product. The course of the reaction was followed spectrophotometrically at 725 nm. The initial rates of reaction for different concentrations of pantoprazole at 308 K were determined from the slopes of the initial tangent to the absorbance-time curves (Fig. 1) ; these rates are summarized in (1)
Under the optimized experimental conditions, i.e. CFe(III) ≥ 5.10 × 10 -4 M and Cferricyanide ≥ 3.75 × 10 -4 M, the reaction became pseudo-zero order with respect to the reagent concentrations. Therefore, the above equation reduced to ν = k1C n Drug where k1 is the first rate constant and n is the order of the reaction. The order with respect to pantoprazole was evaluated from the plot of log ν versus log C and was found to be 1.
Hence, the reaction would obey the pseudo-first order condition and thus the above equation reduced to ν = k1CDrug.
A calibration graph was constructed by plotting the initial rate of reaction (ν) versus the pantoprazole concentration (C); the graph showed a linear relationship over the concentration range of 5.0 -90.0 μg ml -1 at 308 K. The regression of initial rate versus C gave a linear regression equation, ν = 3.467 × 10 -6 + 4.356 × 10 -5 C with coefficient of correlation, r = 0.9999. The confidence limits for the slope of the line of regression and intercept were computed using the relation b ± tSb and a ± tSa at 95% confidence level and were found to be 4.356 × 10 -5 ± 4.806 × 10 -7 and 3.467 × 10 -6 ± 2.519 × 10 -5 , respectively. The values of confidence limits for slope and intercept indicated the high reproducibility of the initial rate method. The limits of detection (LOD) and quantitation (LOQ) were found to be 1.46 and 4.43 μg ml -1 , respectively. The small value of variance (3.716 × 10 -10 μg ml -1 ) also confirmed the negligible scattering of the calibration data points around the line of regression.
Solution stability and selectivity
Pantoprazole is stable under neutral to moderately acidic conditions (pH ∼3.5 -7.4). 19 The solution stability of pantoprazole was checked by observing UV spectra of pantoprazole for 14 h. The aqueous solution of the drug having λmax at 298 nm showed no changes in the absorption spectra of standard and quality control sample solutions of drug for at least 14 h, when the solutions were stored at a temperature < 45˚C.
dx -dt
To identify pantoprazole and pantoprazole sulfone, we used thin layer chromatography. The standard solution, quality control sample solution and oxidized product of pantoprazole were applied on TLC plates coated with silica gel and developed in chloroform-methanol (10:0.7 v/v) solvent system. The plates were air-dried and spots were detected in the iodine chamber. In the case of standard and quality control sample solutions, a single spot was observed with Rf = 0.54 corresponding to pantoprazole, whereas the oxidized product showed one spot with Rf value of 0.66, confirming the presence of pantoprazole sulfone. The proposed kinetic method is a selective one, since the major metabolite of pantoprazole i.e. pantoprazole sulfone does not interfere with the determination process.
Robustness
The robustness of the proposed method was investigated by challenging each operational parameter such as: 1.7 ml of 0.003 M ammonium ferric sulfate in 0.003 M H2SO4 (±0.4 ml); 1.5 ml of 0.0025 M potassium ferricyanide (±0.5 ml); 35˚C (308 K) as the working temperature (±1˚C).
Under these conditions quality control sample solutions from two commercial dosage forms claiminig 60.0 μg ml -1 of active pantoprazole were assayed by performing 5 independent analyses following the proposed kinetic method. The recovery results are appreciable with low values of standard deviation and relative standard deviations.
Accuracy and precision
The accuracy and precision of the proposed kinetic method were established by performing 5 independent analyses of pantoprazole in pure form at three different concentration levels (20, 50 and 80 μg ml -1 ) by intra-day and inter-day precisions. The recovery results with relative standard deviation, standard analytical error and confidence limit are summarized in Table 4 ; they confirm that the accuracy and precision were acceptable. Thus the proposed method is effective for the estimation of pantoprazole.
The accuracy of the proposed kinetic method was also tested by performing recovery experiments through the standard addition method. The recovery was evaluated either by dividing the intercept by the slope value of the line of linear regression of the standard addition method or by the extrapolation of the same line of best fit (Figs. 2 and 3 , Table 5 ). It is evident from Table  5 that the linearity of the regression line of the standard addition method was good. The attractive feature of the method is its relative freedom from interference by the usual tablet diluents and excipients in amounts far in excess of their normal 986 ANALYTICAL SCIENCES JULY 2006, VOL. 22 occurrence in pharmaceutical preparations.
Applicability of the proposed kinetic method
The proposed kinetic method has been successfully applied to the determination of pantoprazole in pharmaceutical preparations. The results obtained by the proposed method were compared to those of the reference method 11 using point and interval hypothesis tests. The results (Table 6) show that the Student's t-and F-values at 95% confidence level are less than the theoretical values, which confirmed that there is no significant difference between the performance of the proposed kinetic method and the reference method. The interval hypothesis test has also confirmed that no significant difference exists between the performances of the methods compared, as the true bias of all drug samples is < ±2.0%.
The performance of the proposed kinetic spectrophotometric method was compared with other existing conventional spectrophotometric methods (Table 7) . It is apparent from Table 7 that the present procedure requires 4 min only for obtaining the initial rate of reaction, which is proportional to the concentration of pantoprazole. The reaction of pantoprazole with ammonium ferric sulfate and potassium ferricyanide requires 30 min to develop a stable color, which is mandatory for conventional spectrophotometric methods. Thus, the time of analysis is reduced when the kinetic spectrophotometric procedure was applied.
The other conventional spectrophotometric methods using FeCl3 10 and eosin and copper 11 need longer times to record the absorbance, whereas the method utilizing 2,3-dichloro-5,6-dicyano-1,4-benzoquinone 11 gives a stable color instantaneously. The drawback of these methods is that they employ an organic solvent while the proposed kinetic method is carried in an aqueous system. 987 ANALYTICAL SCIENCES JULY 2006, VOL. 22 
Conclusions
The proposed kinetic method is a selective one as the drug contains sulfoxide group, which preferentially reduces Fe(III) to Fe(II); subsequently Fe(II) reacts with potassium ferricyanide to form Prussian blue. In human and animals, pantoprazole is metabolized to pantoprazole sulfone, which did not give a positive result with the reagents used. This is a remarkable advantage of the method that Fe(III) in the presence of potassium ferricyanide selectively reacts with pantoprazole and give Prussian blue product. Point and interval hypothesis tests clearly proved that the proposed method has acceptable recovery with a bias of less than ±2%. The method is also useful due to its wide linear dynamic range (5.0 -90.0 μg ml -1 ) and high tolerance limit for common excipients found in drug formulations. Hence, these advantages encourage the application of the proposed kinetic method in routine quality control analysis of pantoprazole in industries, research laboratories and hospitals.
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